CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$55.43 -0.01 (-0.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) Income from Non-Controlling Interests (2015 - 2016)

Updated

CRISPR Therapeutics AG's Income from Non-Controlling Interests came in at -$1,000 for Q4 2016, compared with -$16,000 a year earlier.

Analysis

CRISPR Therapeutics AG (CRSP) Income from Non-Controlling Interests (2015 - 2016) Analysis & Trends

For FY2016, CRISPR Therapeutics AG's Income from Non-Controlling Interests was -$25,000.

  • Going back by year, Income from Non-Controlling Interests was -$325,000 in FY2015 and -$536,000 in FY2014.
  • Business Quant data shows CRSP's Income from Non-Controlling Interests at -$14,000 (Q3 2016), -$7,000 (Q2 2016) and -$3,000 (Q1 2016) in the three quarters before Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -2.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -7.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 10.00 Mn
10 CRISPR Therapeutics AG 5.36 Bn 5.36 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -1,000.00
Sep 30, 2016 -14,000.00
Jun 30, 2016 -7,000.00
Mar 31, 2016 -3,000.00
Dec 31, 2015 -16,000.00
Sep 30, 2015 -1,000.00
API Access

CRISPR Therapeutics AG Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CRSP&period=max&api_key=YOUR_API_KEY